Evaluation of the Effectiveness of ST266 Ophthalmic Drops Compared to Placebo to Treat Allergic Conjunctivitis
Status:
Completed
Trial end date:
2017-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy of ST266 ophthalmic drops compared to
placebo for the treatment of the signs and symptoms of allergic conjunctivitis.